Keli Walbert

Sales & Marketing bei HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY

Consumer Services

Health Technology

Profil

Keli Walbert is currently the Chief Marketing Officer & Executive Vice President at Horizon Therapeutics Plc.
She has a graduate degree from Northwestern University and an undergraduate degree from the University of Louisville.

Aktive Positionen von Keli Walbert

Unternehmen	Position	Beginn
HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY	Sales & Marketing	01.01.2018

Alle aktiven Positionen von Keli Walbert

Ausbildung von Keli Walbert

Northwestern University	Graduate Degree
University of Louisville	Undergraduate Degree

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Keli Walbert im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	1
Horizon Therapeutics Plc Horizon Therapeutics Plc Pharmaceuticals: MajorHealth Technology Horizon Therapeutics Plc is a biopharmaceutical company, which engages in the research, development, and marketing of pharmaceutical products. It operates through the Orphan and Inflammation segments. The Orphan segment consists of medicines KRYSTEXXA, RAVICTI, PROCYSBI, ACTIMMUNE, BUPHENYL, QUINSAIR, and RAYOS. The Inflammation segment comprises medicines PENNSAID 2%, DUEXIS, and VIMOVO. The company was founded in 2008 and is headquartered in Dublin, Ireland.	Health Technology